Microsurgical Innovations Inc
Salt Lake City, UT · Medtech · Private
A patented nerve conduit device that delivers neurotrophic molecules in controlled manner to promote peripheral nerve regeneration
- Grants
- $5.6M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · A Biodegradable Vascular Coupling Device for End-to-End Anastomosis | $146,312 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · A Biodegradable Vascular Coupling Device for End-to-End Anastomosis | $146,312 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · A Biodegradable Vascular Coupling Device for End-to-End Anastomosis | $750,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · A Biodegradable Vascular Coupling Device for End-to-End Anastomosis | $1,466,196 | |
| Federal grant | Department of Health and Human Services · Phase II · A Biodegradable Vascular Coupling Device for End-to-End Anastomosis | $716,196 | |
| Federal grant | Department of Health and Human Services · Phase I · A novel biodegradable nerve conduit drug delivery device for peripheral nerverepair | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A novel biodegradable nerve conduit drug delivery device for peripheral nerverepair | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Tacrolimus-eluting nerve guidance conduit for enhanced regeneration in critical-sized peripheral nerve injuries | $919,846 | |
| Federal grant | Department of Health and Human Services · Phase II · Tacrolimus-eluting nerve guidance conduit for enhanced regeneration in critical-sized peripheral nerve injuries | $1,005,546 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 661 | ASC Mercer Island LLC | — | $1.9M |
| 662 | Vibrato Medical, Inc. | — | — |
| 663 | Sight Sciences, Inc. | — | $102M |
| 664 | Microsurgical Innovations Inc | — | — |
| 665 | EXACT SCIENCES THRIVE LLC | — | — |
| 666 | ACTIV SITTING, INC. | — | — |
| 667 | CHISQUARE BIOIMAGING, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.